Altimmune, Inc. (ALT)
3.255
+0.02
(+0.77%)
USD |
NASDAQ |
Sep 16, 13:33
Altimmune Price : 3.255 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 3.30 | 3.31 | 3.21 | 3.23 | 2.339M |
| Sep 14, 2026 | 3.27 | 3.36 | 3.27 | 3.30 | 2.466M |
| Sep 11, 2026 | 3.33 | 3.41 | 3.26 | 3.27 | 2.705M |
| Sep 10, 2026 | 3.32 | 3.345 | 3.25 | 3.29 | 2.563M |
| Sep 09, 2026 | 3.35 | 3.425 | 3.291 | 3.35 | 3.076M |
| Sep 08, 2026 | 3.46 | 3.550 | 3.34 | 3.36 | 3.592M |
| Sep 04, 2026 | 3.28 | 3.43 | 3.25 | 3.42 | 4.872M |
| Sep 03, 2026 | 3.30 | 3.32 | 3.19 | 3.23 | 2.552M |
| Sep 02, 2026 | 3.10 | 3.34 | 3.10 | 3.28 | 7.472M |
| Sep 01, 2026 | 3.07 | 3.095 | 3.02 | 3.09 | 2.355M |
| Aug 31, 2026 | 3.08 | 3.135 | 3.06 | 3.11 | 2.216M |
| Aug 28, 2026 | 3.21 | 3.23 | 3.06 | 3.11 | 3.194M |
| Aug 27, 2026 | 3.19 | 3.25 | 3.130 | 3.24 | 2.279M |
| Aug 26, 2026 | 3.20 | 3.20 | 3.09 | 3.15 | 4.051M |
| Aug 25, 2026 | 3.14 | 3.225 | 3.11 | 3.20 | 3.820M |
| Aug 24, 2026 | 3.13 | 3.13 | 3.025 | 3.11 | 2.725M |
| Aug 21, 2026 | 2.98 | 3.24 | 2.95 | 3.11 | 6.157M |
| Aug 20, 2026 | 3.07 | 3.08 | 2.92 | 2.95 | 4.681M |
| Aug 19, 2026 | 3.04 | 3.20 | 3.005 | 3.12 | 10.82M |
| Aug 18, 2026 | 2.99 | 3.03 | 2.96 | 2.97 | 2.472M |
| Aug 17, 2026 | 2.94 | 3.02 | 2.90 | 3.00 | 4.057M |
| Aug 14, 2026 | 2.95 | 2.97 | 2.86 | 2.94 | 3.074M |
| Aug 13, 2026 | 2.95 | 2.96 | 2.84 | 2.88 | 4.109M |
| Aug 12, 2026 | 3.05 | 3.20 | 2.92 | 2.93 | 6.046M |
| Aug 11, 2026 | 3.06 | 3.08 | 2.98 | 3.00 | 3.635M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Protalix Biotherapeutics, Inc. | 2.62 |
| Taysha Gene Therapies, Inc. | 5.06 |
| Humacyte, Inc. | 0.5835 |
| Liquidia Corp. | 69.05 |
| Agenus, Inc. | 7.14 |
Price Related Metrics
| PS Ratio | 13123.34 |
| Price to Book Value | 1.335 |
| Earnings Yield | -24.24% |
| Market Cap | 633.01M |